School of Medicine

Showing 11-12 of 12 Results

• 

  Jeffrey Dunn, MD

  Clinical Professor, Neurology & Neurological Sciences

  Current Research and Scholarly Interests Translational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.

• 

  Emmanuel During, MD

  Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine

  Current Research and Scholarly Interests Improving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.
  
  Controlling symptoms of RBD testing drugs rigorously.
  
  Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome